WallStSmart

Alcon AG (ALC)vsThe Cooper Companies, Inc (COO)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Alcon AG generates 156% more annual revenue ($10.86B vs $4.24B). COO leads profitability with a 13.5% profit margin vs 5.9%. COO appears more attractively valued with a PEG of 0.52. COO earns a higher WallStSmart Score of 71/100 (B).

ALC

Buy

51

out of 100

Grade: C-

Growth: 4.7Profit: 4.5Value: 3.3Quality: 6.8
Piotroski: 3/9

COO

Strong Buy

71

out of 100

Grade: B

Growth: 6.7Profit: 5.5Value: 8.0Quality: 6.5
Piotroski: 4/9Altman Z: 2.65
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ALCSignificantly Overvalued (-22.2%)

Margin of Safety

-22.2%

Fair Value

$64.96

Current Price

$64.87

$0.09 premium

UndervaluedFair: $64.96Overvalued
COOUndervalued (+60.4%)

Margin of Safety

+60.4%

Fair Value

$209.49

Current Price

$54.12

$155.37 discount

UndervaluedFair: $209.49Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ALC2 strengths · Avg: 9.5/10
Price/BookValuation
1.5x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.259/10

Conservative balance sheet, low leverage

COO4 strengths · Avg: 9.0/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

EPS GrowthGrowth
357.1%10/10

Earnings expanding 357.1% YoY

PEG RatioValuation
0.528/10

Growing faster than its price suggests

Operating MarginProfitability
20.8%8/10

Strong operational efficiency at 20.8%

Areas to Watch

ALC4 concerns · Avg: 2.8/10
Return on EquityProfitability
3.0%3/10

ROE of 3.0% — below average capital efficiency

Profit MarginProfitability
5.9%3/10

5.9% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

P/E RatioValuation
50.5x2/10

Premium valuation, high expectations priced in

COO2 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.6%4/10

0.6% revenue growth

Return on EquityProfitability
6.8%3/10

ROE of 6.8% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : ALC

The strongest argument for ALC centers on Price/Book, Debt/Equity. PEG of 1.18 suggests the stock is reasonably priced for its growth.

Bull Case : COO

The strongest argument for COO centers on Price/Book, EPS Growth, PEG Ratio. PEG of 0.52 suggests the stock is reasonably priced for its growth.

Bear Case : ALC

The primary concerns for ALC are Return on Equity, Profit Margin, Piotroski F-Score. A P/E of 50.5x leaves little room for execution misses.

Bear Case : COO

The primary concerns for COO are Revenue Growth, Return on Equity.

Key Dynamics to Monitor

COO carries more volatility with a beta of 0.82 — expect wider price swings.

ALC is growing revenue faster at 8.7% — sustainability is the question.

ALC generates stronger free cash flow (414M), providing more financial flexibility.

Monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

COO scores higher overall (71/100 vs 51/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Alcon AG

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Alcon, Inc., an eye care company, researches, develops, manufactures, distributes and sells eye care products for eye care professionals and their patients around the world. The company is headquartered in Geneva, Switzerland.

Visit Website →

The Cooper Companies, Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

The Cooper Companies, Inc., branded as CooperCompanies, is a global medical device company headquartered in San Ramon, California.

Visit Website →

Want to dig deeper into these stocks?